Philippines Pharmaceuticals and Healthcare Report Q1 2015

Date: December 17, 2014
Pages: 129
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF), Download
ID: P6B349D12C4EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: Our outlook for the Philippines' pharmaceutical sector remains bullish, driven by an increasing population and high burden of disease profile. Generic medicines will continue to account for an increasing share of pharmaceutical sales in the Philippines, galvanised by expanding government provision of healthcare as well as improvements in generic drug distribution. This provides strong growth opportunities for generic drug manufacturers in an emerging market where economic growth will be sustained by robust private consumption. However, current access to medicines and treatment will continue to negatively impact the wider market.

Headline Expenditure Projections
  • Pharmaceuticals: PHP140.20bn (USD3.25bn) in 2013, rising to PHP145.05bn (USD3.26bn) in 2014; +3.5% in local currency terms and +0.4% in US dollar terms.
  • Healthcare: PHP545.09bn (USD12.62bn) in 2013, rising to PHP612.04bn (USD13.75bn) in 2014; +12.3% in local currency terms and +9.0% in US dollar terms.
BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Philippines 2010-2018)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018)
  Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018)
  Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Philippines 2010-2018)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Philippines 2010-2018)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Philippines 2012-2018)
  Table: Pharmaceutical Trade Data And Forecasts local currency (Philippines 2012-2018)
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
  Table: Economic Activity (Philippines 2009-2018)
Industry Risk Reward Ratings
Asia Pacific Risk/Reward Index
Philippines Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Health Insurance
Healthcare Sector Financing
Medical Tourism
Biotechnology And Research
Traditional Medicines
Clinical Trials
Regulatory Development
  Table: History Of Food And Drugs Administration
Intellectual Property Regime
Pricing Regime
  Table: Medicines Subject To March 31 2010 Government Mediated Access Price
Reimbursement Regime
International Cooperation
Competitive Landscape
Pharmaceutical Industry
  Table: Pharmaceutical Industry Overview
Domestic Pharmaceutical Industry
Pharmaceutical Distribution and Retail
  Table: Overview Of BnB, BNB and P100 Programme
  Table: Cost Of Generic Drugs In Philippines (PHP)
  Table: Number Of BnBs And BNBs In Selected Philippine Regions
Company Profile
Unilab
Pascual Laboratories
Pacific Pharmaceutical Generics
MediChem Pharmaceuticals
GlaxoSmithKline Philippines
Pfizer
Novartis
Merck & Co
Sanofi
Demographic Forecast
  Table: Population Headline Indicators (Philippines 1990-2025)
  Table: Key Population Ratios (Philippines 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Philippines 1990-2025)
  Table: Population By Age Group (Philippines 1990-2025)
  Table: Population By Age Group % (Philippines 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top


Ask Your Question

Philippines Pharmaceuticals and Healthcare Report Q1 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: